Ortho Clinical Diagnostics Holdings plc. (OCDX) NASDAQ

$17.63 0 (0.00%)

Market Cap: $0

As of 05/26/22 12:00 AM EDT. Market closed.

(OCDX)

Ortho Clinical Diagnostics Holdings plc. (OCDX) NASDAQ

$17.63 0 (0.00%)

Market Cap: $0

As of 05/26/22 12:00 AM EDT. Market closed.

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions. Because Every Test is a Life™, Ortho Clinical Diagnostics never stops innovating to offer streamlined, sustainable laboratory solutions that deliver fast, accurate, reliable test results that support exceptional ... read more

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions. Because Every Test is a Life™, Ortho Clinical Diagnostics never stops innovating to offer streamlined, sustainable laboratory solutions that deliver fast, accurate, reliable test results that support exceptional patient care. As a trusted partner of hospitals, hospital networks, blood banks, and labs around the world, Ortho Clinical Diagnostics serves the clinical laboratory and transfusion medicine communities with customized solutions that enhance clinical outcomes, improve lab performance, overcome staffing challenges and better manage costs. Ortho Clinical Diagnostics is powered by Ortho Care™, its global, award-winning, holistic approach to service, which supports customers with best-in-class technical support, award-winning field support, and remote service and inventory support. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$17.63
Previous Close
$17.63
Days Range
$17.47 - $17.79
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
237,734,877
Open
$17.63
Previous Close
$17.63
Days Range
$17.47 - $17.79
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
237,734,877

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Schlesinger Michael A. EVP, GC and Secretary Apr 04, 2022 Option Exercise $6.28 88,043 552,910 175,680 Apr 06, 2022, 04:05 PM
Schlesinger Michael A. EVP, GC and Secretary Apr 04, 2022 Sale $18.77 88,043 1,652,241 87,637 Apr 06, 2022, 04:05 PM
Yates Robert Clifton Director Mar 31, 2022 Option Exercise $18.66 214 3,993 4,218 Apr 04, 2022, 04:05 PM
Yates Robert Clifton Director Jan 03, 2022 Option Exercise $21.12 214 4,520 4,432 Jan 05, 2022, 04:24 PM
Smith Christopher M Chairman and CEO Jan 03, 2022 Option Exercise $12.56 100,000 1,256,000 467,360 Jan 05, 2022, 04:23 PM
Smith Christopher M Chairman and CEO Jan 03, 2022 Sale $21.10 100,000 2,109,800 367,360 Jan 05, 2022, 04:23 PM
Schlesinger Michael A. EVP, GC and Secretary Jan 03, 2022 Option Exercise $6.28 130,000 816,400 217,637 Jan 05, 2022, 04:23 PM
Schlesinger Michael A. EVP, GC and Secretary Jan 03, 2022 Sale $21.09 130,000 2,741,622 87,637 Jan 05, 2022, 04:23 PM
Schlesinger Michael A. EVP, GC and Secretary Oct 15, 2021 Option Exercise $6.28 75,464 473,914 163,101 Oct 19, 2021, 04:15 PM
Schlesinger Michael A. EVP, GC and Secretary Oct 15, 2021 Sale $19.73 75,464 1,489,010 87,637 Oct 19, 2021, 04:15 PM
Yates Robert Clifton Director Sep 30, 2021 Option Exercise $18.48 277 5,119 4,646 Oct 04, 2021, 04:13 PM
Yates Robert Clifton Director Aug 05, 2021 Option Exercise $20.69 277 5,731 4,923 Oct 04, 2021, 04:13 PM
Carlyle Group Inc. 10% Owner Sep 14, 2021 Sale $16.80 25,300,000 425,039,981 118,106,000 Sep 16, 2021, 04:30 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 18, 2021 Option Exercise $6.28 41,015 257,574 128,652 Aug 18, 2021, 05:41 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 16, 2021 Option Exercise $6.28 4,000 25,120 91,637 Aug 18, 2021, 05:41 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 18, 2021 Sale $20.14 41,015 826,013 87,637 Aug 18, 2021, 05:41 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 16, 2021 Sale $20.03 4,000 80,110 87,637 Aug 18, 2021, 05:41 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 12, 2021 Option Exercise $6.28 8,100 50,868 95,737 Aug 13, 2021, 05:22 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 11, 2021 Option Exercise $6.28 72,585 455,834 160,222 Aug 13, 2021, 05:22 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 13, 2021 Option Exercise $6.28 4,300 27,004 91,937 Aug 13, 2021, 05:22 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 12, 2021 Sale $20.00 8,100 162,003 87,637 Aug 13, 2021, 05:22 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 11, 2021 Sale $19.76 72,585 1,434,621 87,637 Aug 13, 2021, 05:22 PM
Schlesinger Michael A. EVP, GC and Secretary Aug 13, 2021 Sale $20.00 4,300 86,003 87,637 Aug 13, 2021, 05:22 PM
Yates Robert Clifton Director Aug 02, 2021 Option Exercise $6.28 23,062 144,829 346,942 Aug 04, 2021, 06:29 PM
Yates Robert Clifton Director Aug 03, 2021 Sale $21.59 176,149 3,803,110 145,242 Aug 04, 2021, 06:29 PM
Yates Robert Clifton Director Aug 02, 2021 Sale $22.06 25,551 563,640 321,391 Aug 04, 2021, 06:29 PM
Yates Robert Clifton Director Aug 04, 2021 Sale $21.79 140,042 3,051,515 5,200 Aug 04, 2021, 06:29 PM
Smith Christopher M Chairman and CEO Aug 02, 2021 Sale $22.10 103,213 2,281,038 534,147 Aug 04, 2021, 06:29 PM
Smith Christopher M Chairman and CEO Aug 04, 2021 Sale $21.79 61,800 1,346,622 367,360 Aug 04, 2021, 06:29 PM
Smith Christopher M Chairman and CEO Aug 03, 2021 Sale $21.55 104,987 2,262,827 429,160 Aug 04, 2021, 06:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Schlesinger Michael A. EVP, GC and Secretary 04/04/2022 552,910
Schlesinger Michael A. EVP, GC and Secretary 04/04/2022 1,652,241
Yates Robert Clifton Director 03/31/2022 3,993
Yates Robert Clifton Director 01/03/2022 4,520
Smith Christopher M Chairman and CEO 01/03/2022 1,256,000
Smith Christopher M Chairman and CEO 01/03/2022 2,109,800
Schlesinger Michael A. EVP, GC and Secretary 01/03/2022 816,400
Schlesinger Michael A. EVP, GC and Secretary 01/03/2022 2,741,622
Schlesinger Michael A. EVP, GC and Secretary 10/15/2021 473,914
Schlesinger Michael A. EVP, GC and Secretary 10/15/2021 1,489,010
Yates Robert Clifton Director 09/30/2021 5,119
Yates Robert Clifton Director 08/05/2021 5,731
Carlyle Group Inc. 10% Owner 09/14/2021 425,039,981
Schlesinger Michael A. EVP, GC and Secretary 08/18/2021 257,574
Schlesinger Michael A. EVP, GC and Secretary 08/16/2021 25,120
Schlesinger Michael A. EVP, GC and Secretary 08/18/2021 826,013
Schlesinger Michael A. EVP, GC and Secretary 08/16/2021 80,110
Schlesinger Michael A. EVP, GC and Secretary 08/12/2021 50,868
Schlesinger Michael A. EVP, GC and Secretary 08/11/2021 455,834
Schlesinger Michael A. EVP, GC and Secretary 08/13/2021 27,004
Schlesinger Michael A. EVP, GC and Secretary 08/12/2021 162,003
Schlesinger Michael A. EVP, GC and Secretary 08/11/2021 1,434,621
Schlesinger Michael A. EVP, GC and Secretary 08/13/2021 86,003
Yates Robert Clifton Director 08/02/2021 144,829
Yates Robert Clifton Director 08/03/2021 3,803,110
Yates Robert Clifton Director 08/02/2021 563,640
Yates Robert Clifton Director 08/04/2021 3,051,515
Smith Christopher M Chairman and CEO 08/02/2021 2,281,038
Smith Christopher M Chairman and CEO 08/04/2021 1,346,622
Smith Christopher M Chairman and CEO 08/03/2021 2,262,827
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
04/03/2022
01/02/2022
6.05%
1Q
04/03/2022
10/03/2021
7.36%
2Q
04/03/2022
07/04/2021
9.80%
3Q

Period of Report: 04/03/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
01/02/2022
6.05%
1Q
10/03/2021
7.36%
2Q
07/04/2021
9.80%
3Q